Centessa Pharmaceuticals stock pops 20%+ to record high (NASDAQ:CNTA)

Centessa Pharmaceuticals (Nasdaq:CNTA) rebounded by more than 20% intraday Monday to a new post-IPO high despite no apparent news for the stock.
Read More